Amyris plans to acquire MenoLabs to boost menopause health
25 Jan 2022 --- Synthetic biotechnology company Amyris is stepping into the menopausal health space by acquiring the assets of MenoLabs LLC, a company aimed at aiding and raising awareness about perimenopause and menopause symptoms.
The acquisition, in combination with a menopause brand in collaboration with Actress Naomi Watts, incentivizes a step up in the menopause market, with an estimate of US$30 million in revenue just in the first year, says John Melo, company president and CEO.
Amyris will acquire MenoLabs products and the MenoLife health app, which allows people to track their menopause symptoms. This will allow Amyris to continue diversifying its offering in “Clean Beauty, Health and Wellness end-markets, says Melo.
Amyris predicts by 2025, approximately over one billion people (12%) will be experiencing menopause. Additionally, menopause symptoms affect about 25 million people each year - that is 2.2 million people in the US alone.
Science-backed, hormone-free alternatives
Both lab-based establishments have a synergy toward science-backed research to approach “health and wellness issues,” says Melo. Additionally, both companies are aligned by producing clean beauty.
Furthermore, MenoLabs aligns with natural treatment, thus offering all-natural and vegan menopause relief supplements formulated by doctors. Examples include MenoFit and Athena’s Shield, both of which contain probiotics. 
Amyris believes all beauty products will be made with clean chemistry in the future.
Probiotics have proved to be a natural way of improving and caring for vaginal health.
Due to a lack of hormone-free alternatives to alleviate menopausal symptoms, consumers’ demand for natural remedies increases.
Pairing science with wellness can empower people to care for their bodies and well-being. “We are committed to empowering women and creating a platform to support them,” asserts Melo.
Companies like Holland & Barrett are normalizing the conversation around the menopausal market for brands to seriously consider menopause with knowledge so that consumers can make informed choices to empower themselves.
The social stigma and secrecy around the experience and suffering of menopause can be broken down with science-backed research aimed at promoting personal care, health and wellness.
In other news on Clean Beauty and Amyris, Amyris researches accelerating fermentation with Onyx; Amyris acquires Terasana to produce sustainably sourced cannabinoids; Amyris partnered with Jonathan Van Ness to launch a clean haircare brand and also acquired Costa Brazil.
In related news on vaginal health, Bonafide released Clairvee (oral probiotic for restoring and balancing the vaginal microbiome); Pharmavite offered Equelle (non-prescriptive, hormone-free dietary supplement); yoni steaming as an alternative therapy may aid menopause symptoms; L’Oréal partnered with Clue, developing a period tracking app to research the relationship between skin health and menstrual cycles (including menopause).
Edited by Venya Patel
